Developing a continuous, real-time monitoring system for transplant organ function, beginning with kidneys.
Accunea has raised $250K in total funding. The most recent round was Seed. The last funding was announced in March 2022.
Accunea's investors include Newchip Accelerator.
Accunea is headquartered in London, United Kingdom.
Developing a continuous, real-time monitoring system for transplant organ function, beginning with kidneys.
Accunea is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Accunea — Funding & Investors." VCBacked, March 25, 2022, https://www.vcbacked.co/company/accunea. Accessed July 22, 2026.
VCBacked. (2022). Accunea — Funding & Investors. Retrieved July 22, 2026, from https://www.vcbacked.co/company/accunea
{{cite web |title=Accunea — Funding & Investors |url=https://www.vcbacked.co/company/accunea |website=VCBacked |access-date=July 22, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated